Traits associated with innate and adaptive immunity in pigs: heritability and associations with performance under different health status conditions by Clapperton, Mary et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Genetics Selection Evolution
Open Access Research
Traits associated with innate and adaptive immunity in pigs: 
heritability and associations with performance under different 
health status conditions
Mary Clapperton*1, Abigail B Diack2, Oswald Matika1, Elizabeth J Glass1, 
Christy D Gladney3, Martha A Mellencamp4, Annabelle Hoste5 and 
Stephen C Bishop1
Address: 1The Roslin Institute and Royal Dick School of Veterinary Studies, University of Edinburgh, Roslin, Midlothian, EH25 9PS, UK, 2Faculty 
of Veterinary Medicine, University of Glasgow, G61 IQH, UK, 3Genus, De Forest, WI 53532, USA, 4Ralco Nutrition, Inc., 1600 Hahn Road, 
Marshall, MN 56258, USA and 5JSR Genetics Ltd, Driffield, East Yorkshire, Y025 9ED, UK
Email: Mary Clapperton* - Mary.Clapperton@roslin.ed.ac.uk; Abigail B Diack - abigail.diack@roslin.ed.ac.uk; 
Oswald Matika - Oswald.Matika@roslin.ed.ac.uk; Elizabeth J Glass - liz.glass@roslin.ed.ac.uk; Christy D Gladney - Christy.Gladney@pic.com; 
Martha A Mellencamp - marnie.mellencamp@ralconutrition.com; Annabelle Hoste - annabelle.hoste@jsrgenetics.com; 
Stephen C Bishop - Stephen.Bishop@roslin.ed.ac.uk
* Corresponding author    
Abstract
There is a need for genetic markers or biomarkers that can predict resistance towards a wide range
of infectious diseases, especially within a health environment typical of commercial farms. Such
markers also need to be heritable under these conditions and ideally correlate with commercial
performance traits. In this study, we estimated the heritabilities of a wide range of immune traits,
as potential biomarkers, and measured their relationship with performance within both specific
pathogen-free (SPF) and non-SPF environments. Immune traits were measured in 674 SPF pigs and
606 non-SPF pigs, which were subsets of the populations for which we had performance
measurements (average daily gain), viz. 1549 SPF pigs and 1093 non-SPF pigs. Immune traits
measured included total and differential white blood cell counts, peripheral blood mononuclear
leucocyte (PBML) subsets (CD4+ cells, total CD8α+ cells, classical CD8αβ+ cells, CD11R1+ cells
(CD8α+ and CD8α-), B cells, monocytes and CD16+ cells) and acute phase proteins (alpha-1 acid
glycoprotein (AGP), haptoglobin, C-reactive protein (CRP) and transthyretin). Nearly all traits
tested were heritable regardless of health status, although the heritability estimate for average daily
gain was lower under non-SPF conditions. There were also negative genetic correlations between
performance and the following immune traits: CD11R1+ cells, monocytes and the acute phase
protein AGP. The strength of the association between performance and AGP was not affected by
health status. However, negative genetic correlations were only apparent between performance
and monocytes under SPF conditions and between performance and CD11R1+ cells under non-SPF
conditions. Although we cannot infer causality in these relationships, these results suggest a role
for using some immune traits, particularly CD11R1+ cells or AGP concentrations, as predictors of
pig performance under the lower health status conditions associated with commercial farms.
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Background
The control of infection represents a major challenge to
the pig industry. Over the last decade, this challenge has
become greater due to the spread of viral infections such
as PMWS (post-weaning multi-systemic wasting syn-
drome), PRRS (porcine reproductive and respiratory syn-
drome) and enzootic pneumonia. In addition to the
impact of these infections or diseases upon pig morbidity
and mortality, they can also affect pig health by increasing
susceptibility to secondary bacterial infections [1-3].
Since antibiotics and bio-security control measures can
only partially control infection, and effective vaccines are
not always available, it would be advantageous to find a
method of selecting pigs with increased resistance to a
wide range of infectious diseases or an increased ability to
maintain high performance levels in the face of disease
pressure. In pig breeding companies, pigs are generally
selected for improved performance within the high health
status environment of a nucleus farm, but often their
progeny are reared within a lower health status environ-
ment and, as a result, their performance may be compro-
mised. Hence there is a need to find a way of selecting
boars that can produce progeny with an increased resist-
ance to a wide range of infectious diseases so that they are
able to perform well under a range of health conditions.
In pig production systems it is difficult to select animals
directly for disease resistance since the major challenges
often differ in different environments and most hus-
bandry practices attempt to minimise exposure to infec-
tion. Therefore, an alternative approach is needed. One
such approach would be to use measures of innate and
adaptive immunity which are heritable and associated
with parameters related to health and/or performance. In
order to predict progeny that will perform equally well in
a range of environments, these immune markers would
have to be heritable regardless of health status.
Previously, we have shown peripheral blood mononu-
clear leucocyte (PBML) subsets to be heritable [4]. Fur-
ther, CD11R1+ cells, a subset consisting of natural killer
(NK) cells and NK T cells, [5,6] were also genetically neg-
atively correlated with performance [4]. It may be hypoth-
esized that this type of association reflects an underlying
response to infection, and this result can be explored by
comparing the genetic relationship between CD11R1+
cells and performance under both high and lower health
status environments. Significant genetic relationships
with performance under lower health status environ-
ments would suggest that they can be used as biomarkers
for health or performance in such environments. We still
need to satisfactorily quantify the effect of health status on
the properties of these immune traits, particularly their
heritabilities and correlations with performance.
Added insight into the utility of measuring the PBML sub-
sets may also be gained by refining their definitions. For
example, in our previous study [4], we did not account for
the presence of the different CD8α+  subsets that are
unique to pig PBML. In addition to classical CD8αβ+ cells,
these subsets include CD4+CD8α+ cells, CD8α+ γδ+ T cells
and CD8α+ NK cells [7]. In particular, CD4+ CD8α+ cells
have been suggested to be memory CD4+ helper cells [8,9]
and hence, an important component of the adaptive
immune response. It is also possible to distinguish
between CD8αβ+ cells and CD8αα+ subsets on the basis of
CD8α expression since CD8αβ+ cells express higher levels
of CD8 antigen compared to CD8αα+ cells [7]. Further
PBML subsets of importance that we can define include
CD14+  and CD16+  cells. Within pig PBML, CD16 is
expressed on NK cells and monocytes [6,10,11] whilst, in
pigs, CD14 is a marker of monocyte differentiation [12].
Lastly, CD11R1+ cells may be sub-divided into CD8α+ and
CD8α- subsets since these cell subsets differ according to
cell size, complexity and phenotype [13] (Clapperton,
unpublished observations).
In addition to PBML subsets, we have also reported that
acute phase proteins (APP) have a negative phenotypic
correlation with daily weight gain and food efficiency
[14]. One possible interpretation of this effect is that sub-
clinical infection simultaneously leads to both decreased
weight gain and food efficiency and increased APP levels.
This study [14] also found pig line differences in the levels
of the acute phase protein, alpha-1  acid glycoprotein,
which suggested that APP levels may also be under genetic
control. APP such as haptoglobin, transthyretin, alpha-1
acid glycoprotein (AGP) and C-reactive protein (CRP)
have also been shown to act as potential indicators of ani-
mal and farm health status [15-19]. Therefore, these APP
may be valuable as genetic predictors of pig health, the
hypothesis being that low APP values predict increased
performance as a result of lower levels of infection in
selected offspring.
This paper provides a comprehensive analysis of PBML
and APP measurements, and their genetic relationships
with performance, extending our previous results [4]. In
particular, we provide the first estimates of heritability for
all APP that were measured and the newly defined PBML.
Importantly, by substantially increasing the size of our
dataset we can also compare the heritabilities of a large
range of immune traits, and their associations with per-
formance, between high and lower health status environ-
ments. These results should indicate the extent to which
host genotype influences both the basal levels of these
traits and their levels in response to exposure to patho-
gens.Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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Methods
Populations studied and performance trait measurements
Measurements were performed on pigs sampled from
seven farms labelled A to G. Details of numbers of pigs
tested per farm along with the number of sires and full-sib
families (i.e. litters) are shown in Table 1. All pigs tested
were apparently healthy with no clinical signs of infec-
tion. Farm G represented the Roslin Institute farm whilst
farms A to F represented farms from one of the three pig
breeding companies (sources 1-3) who contributed ani-
mals to the study and are cited in the acknowledgements.
In all cases, sows were reared on the same farm as the off-
spring. After birth, the offspring remained with their dams
until age four weeks, whereupon they were weaned and
transferred to flat deck pens and kept in groups of 28-20.
At start of test (ca. 10-13 weeks of age), animals were split
into groups (less than 20 animals) until end of test, except
for Farm G where animals were housed in individual
pens. All animals were housed in straw bed pens. There
was variation between farms with respect to the type of
buildings used and ventilation.
Farms A, B and C were classified as specific pathogen-free
(SPF), i.e. free of all major swine pathogens whilst farms
D, E, F and G were classified as non-SPF. Farms D-G were
free of all major swine pathogens, as determined by clini-
cal examination and serology tests, except for the follow-
ing: Farm D was tested positive for enzootic pneumonia
(Mycoplasma hyopneumoniae) on the basis of serology and
clinical signs, and Farms E and F were positive for porcine
multi-wasting syndrome (PMWS) on the basis of clinical
signs. Farm G was positive for Pasteurella multocida, Actin-
obacillus pleuropneumoniae, Leptospira bratislava and also,
Salmonella typhimurium phage type 104 was detected in
faecal samples from this farm.
A detailed breakdown of the collected data is given in
Table 1. Data from sources 1-3 were split into three gener-
ations, G1, G2 and GX. A small number of sires were
selected from G1 by the breeding companies on perform-
ance attributes and used to produce progeny (G2) using
unrelated dams on the same farm. Immune traits were
measured in all G1 animals and a sample of G2 animals
chosen at random, whilst performance was measured in
all G1 and G2 animals. The G2 pigs located on both the
SPF and non-SPF farms at source 2 were progeny of the
same sires. Generation GX animals comprised popula-
tions from the same breeding companies/lines as G1 or
G2; however their data (immune measures and perform-
ance) were collected three or more years later, and genetic
relationships between GX and G1 or G2 were sparse and
not included in the analyses. In general, different pig
breed-lines were used on different farms, except on farms
B and E, and C and F where common lines were used. Also
Farm F comprised Landrace as well as Large White pigs.
Approximately equal numbers of males and females were
measured.
Animals were blood sampled at end of test (ca. 90 kg) by
collecting blood via the external jugular vein into a tube
containing EDTA or acid citrate dextrose anti-coagulant
for leucocyte subset measurements and a tube containing
lithium heparin for acute phase protein measurements.
Sampling was staggered so that pigs were tested in weekly
groups of 20 to 30 pigs in all farms except Farm G. Sam-
pling for each farm was completed within a period of 3 to
8 weeks except for Farm G where sampling was performed
on groups of 6-8 pigs over a twelve month period. The
liveweights obtained at the start of test (ca. 30 kg) and at
the end of test were retained in this dataset and used to
calculate average daily gain for both blood sampled ani-
mals and their non-sampled littermates.
Table 1: Numbers of pigs tested, sires, lines and families per farm1
Source 1 2 3 4
Farm A B D E C F G
Health status SPF SPF Non-SPF SPF Non-SPF Non-SPF
Generation G1 G2 GX G1 G2 G2 GX G1 G2 GX GX
No. pigs:
Performance 47 684 373 92 259 148 300 94 398 72 175
Immune traits 47 0 373 92 68 59 300 94 0 72 175
APP 0 0 373 0 0 0 300 0 0 72 175
No. groups:
Sires 21 42 27 23 5 2,3 5 2,3 17 10 52 11 55
Full-sib families 33 155 200 53 53 53 121 19 53 18 72
Genetic lines 8 4 2 1 1 1 1 1 1 8 13
B r e e d L W L WL WL W L WL W L WL W L W L R L W
1 For each source, G2 progeny were derived from G1 boars. All pigs tested for immune traits also had performance measurements. 2642 pigs were 
performance tested, 1280 pigs were tested for immune traits and 920 pigs were tested for APP. 2 All sires were measured when they were growing 
pigs. 3These were the same sires.Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
Page 4 of 11
(page number not for citation purposes)
All procedures performed on the animals tested in this
study were approved by the relevant government authori-
ties responsible for animal welfare.
Immune measurements
Leucocyte subset measurements and the storage of plasma
samples for acute phase protein measurements occurred
within 72 h after blood collection. During this time,
blood was stored at room temperature. Total and differen-
tial white blood cell counts (WBC) were measured as
described previously [13]. The proportions of different
peripheral blood mononuclear leucocyte (PBML) subsets
were measured as described previously [13], using flow
cytometry and primary monoclonal antibodies that recog-
nized cell surface markers for CD4, CD8α, gamma delta
(γδ) T cell receptor, immunoglobulin light chain (B cell
marker), CD11R1 (NK cell marker) and SIRPα (monocyte
marker). In addition, we added markers for CD14+ mono-
cytes (clone MIL-2; [20]) and CD16+ cells (clone G7;
[10,11]). Our measurements also incorporated the fol-
lowing CD8α subsets - CD4+ CD8α+ cells and CD4+CD8α-
cells, CD11R1+CD8α+ and CD11R1+CD8α- cells.
CD8α+ cells sub-divide into two clearly distinct subsets
based upon the intensity of staining for CD8α+, into
'bright' and 'dim' populations as previously described [7].
CD8α+ 'bright' cells were CD8α+ cells with high intensity
of expression for CD8α, and CD8α+  'dim' cells were
CD8α+ cells with low intensity of expression for CD8α.
The antigen density for both the different CD8α+ popula-
tions and for the CD8β+ population was calculated using
Qifikit beads (Dako Cytomation, Ely, Cambridgeshire)
according to the manufacturer's instructions.
Plasma from a 5 mL blood sample was used for the meas-
urement of the acute phase proteins, viz. AGP, hap-
toglobin, CRP and transthyretin. Plasma was collected
from each blood sample after centrifugation at 1000 × g
for 10 min and then decanted into a polypropylene tube
and stored at -20°C. AGP was measured using a commer-
cial kit based on a radial immuno-diffusion assay accord-
ing to the manufacturer's instructions (The Metabolic
Institute, Tokyo, Japan). Transthyretin and CRP were
measured using an ELISA as described previously [21,22].
The concentration of haptoglobin was derived from its
haemoglobin binding activity, as described by Eckersall et
al. (1999) [23].
Data analysis
Traits selected for analysis were average daily gain and the
following immune traits, total and differential WBC
count, proportions of PBML subsets and APP levels. PBML
subset proportions included CD8α+ cells, CD11R1+ cells
(CD8α+ and CD8α- subsets), CD4+ T cells (CD8α+ and
CD8α- subsets), γδ+ T cells, B cells, monocytes (SIRPα+
cells), CD14+ cells (monocyte subset) and CD16+ cells
(NK cells and monocytes) and APP included AGP, hap-
toglobin, CRP and transthyretin.
An initial analysis of the data was performed using GEN-
STAT [24] to determine significant fixed effects and to
characterize the data. Since the distributions of most traits
were skewed to the right, log transformations were
required to normalise the data for these traits prior to
analysis. The proportions of mononuclear and polymor-
phonuclear cells were instead square root transformed.
Significant fixed effects for most traits included farm, gen-
eration and genetic line nested within farm, sex and age at
blood sampling. For the non-SPF animals, disease status
was confounded with farm, i.e. different farms had differ-
ent diseases, and Farm F had Landrace as well as LW pigs.
Genetic parameters and their standard errors were esti-
mated using the AS-REML package [25], fitting an animal
model including all known pedigree relationships. Each
trait was fitted against the fixed effects described above
and the random effects fitted in all analyses were the resid-
ual term, the effect of pen plus the direct genetic effect. For
one trait (transthyretin) a general maternal effect, which
could contain both genetic and environmental (litter)
effects, was also significant and fitted. Uni-variate and bi-
variate analyses were performed for each trait described
above using all available data for each trait from all ani-
mals shown in Table 1, i.e. including animals with per-
formance data but no immune measurements as well as
those with both sets of data. The uni-variate and bi-variate
analyses for each trait were then repeated using data from
either only SPF and non-SPF farms. Uni-variate analyses
were performed for all traits, bi-variate analyses were tar-
geted at specific hypotheses.
In order to test whether differences in heritability esti-
mates between SPF and non-SPF conditions were signifi-
cant, a t value was estimated as:
Results
Characteristics of data within specific pathogen-free (SPF) 
and non-SPF environments
Table 1 shows the details of the numbers of pigs tested
along with the number of generations, genetic lines and
pedigree details for each farm. Table 2 summarises the
data for all immune and performance traits tested within
each type of environment. Health status did not affect
either the mean values or the variances for any of the traits
tested with the exception of AGP, which was lower under
non-SPF conditions than SPF conditions (p < 0.01). This
difference could have been caused by differences in either
th h s e h s e h non SPF SPF non SPF
2
SPF
2 =− √ + −− ( )/ [ (.. ( ) ) (.. ( ) )] .
22 2 2Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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health status or line, as these factors were confounded in
the dataset.
Effect of health status on trait heritabilities
Estimated heritabilities obtained using the entire dataset
are shown in Table 3, for all measured traits. Overall, most
of the traits tested were moderately to highly heritable and
significantly different from zero (p < 0.05). In particular,
classical cytotoxic CD8αβ+ cells and the CD4+ subsets
were both highly heritable, with values ranging from 0.37
to 0.75. The expression of CD8α and CD8β antigens were
also highly heritable, ranging from 0.73 to 0.93. However,
for CD16+ cells, the heritability was low and not signifi-
cantly different from zero (h2 (s.e.) 0.09 (0.08)). For acute
phase protein transthyretin, there was a strong maternal
effect which, if not fitted, resulted in an inflated heritabil-
ity estimate (data not shown). For some traits, the varia-
tion contributed by the local environment, represented by
the effect of pen, was also significant (Table 3).
Table 2: Summary of immune and performance traits for pigs 
from SPF and non-SPF farms1
Health status SPF Non-SPF
Number of pigs tested
- immune traits 674 606
- performance traits 1549 1093
Measurement (units) Mean (variance) Mean (variance)
White blood cells 22.2 (16.9) 24.0 (9.4)
MNL% 70.2 (9.10) 71.2 (11.6)
PMNL% 29.9 (9.10) 28.9 (11.6)
PBML subsets:
CD4+ 17.8 (4.87) 18.0 (5.64)
CD8α+ 28.8 (7.16) 27.4 (6.69)
CD4+CD8α+ 7.51 (2.99) 7.29 (3.30)
CD4+CD8α- 10.2 (3.83) 11.3 (3.79)
CD8αβ+ 14.2 (4.57) 11.8 (4.02)
CD11R1+ total 14.0 (4.49) 14.1 (5.38)
CD11R1+CD8α+ 5.57 (2.94) 4.48 (2.61)
CD11R1+CD8α- 8.37 (3.11) 8.43 (3.65)
γδ+ T cells 29.2 (8.36) 33.2 (12.5)
B cells 12.4 (5.33) 14.5 (6.19)
Monocytes 10.6 (4.85) 9.86 (4.09)
CD14+ 5.21 (2.48) 6.18 (3.45)
CD16+ 18.0 (5.00) 18.4 (6.26)
APP, μg/ml:
Haptoglobin 0.78 (0.62) 0.69 (0.65)
TTR 442.6 (170.0) 555.3 (141.7)
CRP 145.6 (164.6) 144.4 (133.0)
AGP 744.8 (278.7) 388.3 (165.3)
ADG, kg/d 0.86 (0.16) 0.85 (0.17)
age (d), at start-test 80.9 (9.4) 94.7 (10.1)
age (d), at end-test 146 (10.4) 151 (12.1)
Ag density:
all CD8α+ cells 34185 (22820) 28936 (6936)
CD8α+ "dim" cells 15423 (9521) 13422 (3330)
CD8α+ "bright" cells 66368 (42468) 61150 (14483)
all CD8β+ cells 27046 (16257) 20692 (4932)
1 White blood cells expressed as no. cells × 106/mL, PBML sub-sets 
expressed as proportion of mononuclear leucocytes and antigen 
density expressed as the number of antibody binding sites per cell 
(see Materials and Methods).
Table 3: Estimates of direct heritability and pen1 variance ratios 
for immune traits and average daily gain2, 3
Trait: Direct h2 (s.e.) Pen variance/σ2 p
White blood cells 0.28 (0.08) NS
MNL 0.21 (0.09) 0.13 (0.04)*
PMNL 0.24 (0.10) 0.10 (0.04)*
PBML subsets:
CD4+ 0.69 (0.09) 0.05 (0.03)*
CD8α+ 0.46 (0.10) NS
CD4+CD8α+ 0.37 (0.11) NS
CD4+CD8α- 0.75 (0.13) NS
CD8αβ+ 0.45 (0.11) NS
CD11R1+ total 0.35 (0.09) NS
CD11R1+CD8α+ 0.38 (0.10) NS
CD11R1+CD8α- 0.25 (0.09) 0.10 (0.05)*
γδ+ T cell 0.39 (0.09) NS
B cells 0.31 (0.09) NS
Monocytes 0.28 (0.09) NS
CD14+ 0.20 (0.11) NS
CD16+ 0.09 (0.08) 0.08 (0.04)*
APP, μg/mL
Haptoglobin 0.23 (0.09) 0.07 (0.04)*
TTR 0.21 (0.15) 0.25 (0.08)*
CRP 0.15 (0.08) 0.07 (0.04)*
AGP 0.48 (0.10) 0.08 (0.04)*
ADG, kg/d 0.25 (0.06) NS
Ag density:
all CD8α+ cells 0.73 (0.17) NS
CD8α+ "dim" cells 0.93 (0.16) NS
CD8α+ "bright" cells 0.73 (0.16) NS
all CD8β+ cells 0.85 (0.15) NS
1 Pen was fitted as a random effect for all traits, but the pen variance is 
only presented when significant. For transthyretin the pen variance 
was not significant, and the maternal variance as a proportion of 
phenotypic variance is presented instead. Maternal effects were not 
significant and were not fitted for all other traits. 
2Mean pig weight at time of measurement was 90 kg.
3 White blood cells expressed as no. cells × 106/mL, PBML sub-sets 
expressed as proportion of mononuclear leucocytes and antigen 
density expressed as the number of antibody binding sites per cell 
(see Materials and Methods).
* p < 0.05.Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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In Tables 4 and 5, the effects of health status on the direct
heritability of immune and performance traits along with
the genetic and residual variances are shown. The effect of
pen was also fitted to all traits, and is shown in cases
where it is significant. Because differences in estimated
heritabilities may be due to changes in either the genetic
or environmental variance, both of these variance compo-
nents are also presented. There is a tendency for the tran-
sition from a high to a lower health status to be associated
with a decrease in heritability, and this change tended to
be more associated with a decrease in the genetic variance
than an increase in the residual variance. The residual var-
iance was often relatively stable particularly for the acute
phase proteins. Notably, the proportions of CD11R1+
cells and CD16+ cells were moderately heritable under SPF
conditions (h2  (s.e.) 0.46 (0.12)) but lowly heritable
under non-SPF conditions (h2  (s.e.) 0.07 (0.08)),
although for CD11R1+  cells the local environmental
effect, i.e. the pen variance, appeared to be high compared
to the average pen variance for other traits. When the pen
effect was not fitted, the estimated heritability for this
measurement was 0.36 (0.14). When the variance for
'pen' was fixed to be the same as for SPF pigs, the esti-
mated heritability (± se) for this measurement was 0.29
(0.14).
However, the opposite trend was observed for some traits,
viz. the proportions of mononuclear and polymorphonu-
clear cells, CD14+ cells and CD8α+ cells. For these traits, a
lower health status environment was associated with
higher genetic variance and this difference was significant
for CD14+ cells (p < 0.05). Indeed, under SPF conditions,
the heritability estimates were not significantly different
from zero for the proportions of mononuclear and poly-
morphonuclear cells and CD14+ cells, but there was a
strong pen effect for mononuclear and polymorphonu-
clear cells within SPF conditions. These two traits will be
correlated with each other since the composite of the two
traits is equal to one hundred percent. CD4+  and
CD4+CD8- cells are also somewhat, albeit not signifi-
cantly, more heritable under SPF conditions (h2 for SPF
and non-SPF conditions were 0.78 and 0.57 for CD4+ cells
and 0.82 and 0.45 for CD4+CD8-  cells). Indeed the
CD4+CD8- subset under SPF conditions had the highest
heritability of all. Heritabilities for CD8 antigen density
measurements were similar under both SPF and non-SPF
conditions (data not shown).
Heritability estimates for the proportion of monocytes
and acute phase protein, AGP were unaffected by health
status. Further, the health status environment did not
affect the maternal effect associated with transthyretin
(0.24 (0.11) for SPF conditions, and 0.24 (0.10) for non-
SPF conditions).
Heritability estimates for average daily gain were lower
under non-SPF conditions compared to SPF conditions (p
< 0.01), due to both lower genetic variance and increased
residual variance. To explore possible effects of the alloca-
tion of different genetic lines to different farms, the data
were reanalyzed using only progeny derived from the
same sires from sources 2 and 3 (see Table 1), which were
Table 4: Direct heritability (h2) estimates for total and differential WBC and PBML subsets for SPF and non-SPF pigs1, 2,
Farm SPF Non-SPF
Trait Direct h2 
(s.e.)
Pen effect 
(s.e.)
Genetic 
variance × 10-1
Residual 
variance × 10-1
Direct h2 
(s.e.)
Pen effect 
(s.e.)
Genetic 
variance × 10-1
Residual 
variance × 10-1
WBC 0.29 (0.13) NS 0.32 0.72 0.28 (0.11) NS 0.21 0.55
MNL% 0.09 (0.10) 0.16 (0.06)* 0.03 2.02 0.29 (0.13) NS 0.96 2.10
PMNL% 0.09 (0.10) 0.17 (0.06)* 0.56 4.60 0.36 (0.14) NS 3.00 5.20
PBML subsets:
CD4+ 0.78 (0.12) NS 187 38.3 0.57 (0.14) 0.06 (0.04)* 147 94.1
CD8α+ 0.35 (0.12) NS 168 306 0.60 (0.16) 0.12 (0.05)* 215 141
CD4+CD8α+ 0.34 (0.15) NS 0.58 1.10 0.37 (0.17) NS 0.46 0.79
CD4+CD8α- 0.82 (0.17) NS 0.95 0.19 0.45 (0.21) NS 0.35 0.43
CD8αβ+ 0.48 (0.16) NS 0.42 0.45 0.36 (0.17) NS 0.32 0.56
CD11R1+ total 0.46 (0.12) NS 0.45 0.52 0.07 (0.08) 0.34 (0.08)* 0.09 0.78
CD11R1+CD8α+ 0.46 (0.13) NS 0.11 0.13 0.31 (0.16) NS 0.73 1.60
CD11R1+CD8α- 0.27 (0.11) 0.13 (0.06)* 0.39 0.88 0.27 (0.14) NS 0.30 0.70
γδ+ T cells 0.46 (0.12) 0.05 (0.04) 233 279 0.30 (0.12) NS 141 317
B cells 0.41 (0.12) NS 0.55 0.80 0.14 (0.11) NS 0.15 0.86
monocytes 0.26 (0.11) 0.11 (0.05)* 0.42 1.00 0.26 (0.13) NS 0.32 0.91
CD14+ 0.04 (0.09) NS 0.08 1.90 0.48 (0.18) NS 1.00 1.10
CD16+ 0.25 (0.13) NS 0.16 0.47 0.05 (0.09) 0.09 (0.05)* 0.04 0.83
1Traits for which the heritability differed significantly between SPF and non-SPF farms are shown in bold (* p < 0.05). 2 White blood cells expressed as no. cells × 106/mL, 
PBML sub-sets expressed as proportion of mononuclear leucocytes and antigen density expressed as the number of antibody binding sites per cell (see Materials and 
Methods).Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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equally distributed between SPF and non-SPF farms. Each
source was made up of a single genetic line. Within this
subset, the same result was observed as for the whole data-
set, i.e. heritability estimates for average daily gain were
lower under non-SPF than SPF conditions (p < 0.05) (data
not shown).
Since the initial weight (start weight) had a significant
effect upon some of the traits, e.g. AGP, uni-variate analy-
ses for each trait were repeated with this factor fitted as an
extra covariate; however this did not affect the heritability
estimates (data not shown).
Effect of health status on correlations of immune traits 
with average daily gain
The effect of health status upon the relationship between
immune traits and average daily gain is shown in Table 6.
Most of the genetic correlations between immune traits
and average daily gain that were significantly different
from zero were negative, i.e. decreasing average daily gain
was associated with increasing values of a particular
immune trait. In particular, there were negative genetic
correlations between average daily gain and the propor-
tions of CD11R1+ cells, monocytes, the acute phase pro-
tein, AGP. There was a strong negative genetic correlation
between the proportions of CD11R1+ cells and average
daily gain under non-SPF conditions but this relationship
was absent under SPF conditions. There were also weak
negative phenotypic correlations between these two traits
under both SPF and non-SPF conditions. For the propor-
tions of monocytes, there were negative genetic and phe-
notypic correlations between this trait and average daily
gain under SPF conditions but not under non-SPF condi-
tions. There were negative genetic and phenotypic correla-
tions between AGP and average daily gain under both
types of environment.
Although there were apparently high genetic correlations
between other immune traits and weight gain, e.g. WBC
and weight gain under non-SPF conditions, these were
not significantly different from zero (p > 0.05).
There was a negative phenotypic correlation between hap-
toglobin and average daily gain, and a weak positive phe-
notypic correlation between the proportions of γδ+ T cells
and average daily gain, with neither of these correlations
being affected by health status. There were weak negative
correlations between average daily gain and the propor-
tion of PMN leucocytes under non-SPF conditions and
between CD14+ cells and average daily gain under SPF
conditions only.
The analysis was repeated for each set of traits with the ini-
tial weight included as an extra covariate. This extra fixed
effect did not affect the genetic or phenotypic relationship
between any of the immune traits tested and average daily
gain except for the correlations with the proportions of
CD11R1+ cells and AGP under non-SPF conditions, and
the correlation with the proportions of monocytes under
SPF conditions. Adding the initial weight as an extra fixed
effect caused the genetic correlation (rg (se)) between
CD11R1+ cells and average daily gain to increase from -
0.68 (0.29) to -0.99 (0.23), and the genetic correlation
between AGP and average daily gain to increase from -
0.72 (0.22) to -0.92 (0.22). Adding the initial weight as an
extra covariate also caused the genetic correlation of aver-
age daily gain with the number of monocytes to decrease
from -0.46 (0.23) to -0.36 (0.19) and this effect was then
no longer significant (0.05 < p < 0.1).
Correlations between acute phase proteins and PBML 
subsets
Phenotypic correlations between acute phase proteins and
PBML subsets were mostly weak (r < 0.2) and not signifi-
cantly different from zero (data not shown). However,
Table 5: Direct heritability (h2) estimates for acute phase proteins and average daily gain for SPF and non-SPF pigs1
SPF Non-SPF
Trait direct h2 
(s.e.)
Pen effect 
(s.e.)
Genetic 
variance × 10-1
Residual 
variance × 10-1
direct h2 
(s.e.)
Pen effect 
(s.e.)
Genetic 
variance × 10-1
Residual 
variance × 10-1
APP, μg/ml:
haptoglobin 0.23 (0.14) 0.11 (0.05)* 1.10 3.20 0.20 (0.11) NS 0.84 3.20
TTR,2 0.28 (0.22) NS 0.24 0.36 0.12 (0.18) NS 0.11 0.51
CRP 0.20 (0.14) NS 1.40 5.60 0.13 (0.10) 0.11 (0.06)* 0.93 5.30
AGP 0.49 (0.14) 0.08 (0.05)* 0.59 0.52 0.48 (0.14) NS 0.56 0.51
ADG, kg/d 0.40 (0.07) 0.09 (0.03)* 0.07 0.09 0.13 (0.07) NS 0.02 0.15
1Traits for which the heritability differed significantly between SPF and non-SPF farms are shown bold (* p < 0.05).
2For transthyretin (TTR), both pen and dam effects were fittedGenetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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some genetic correlations were significantly different from
zero, and these correlations were all positive. In summary,
there was a positive genetic correlation between the con-
centration of C-reactive protein (CRP) and the propor-
tions of B cells (rg = 0.80 (s.e. 0.21)), and between the
concentration of haptoglobin and either the proportions
of monocytes (rg = 0.52 (s.e. 0.24)) or the proportions of
CD11R1+ cells (rg = 0.53 (s.e. 0.21)).
Correlations between different PBML subsets
Nearly all genetic and phenotypic correlations between
different PBML subsets were not statistically significant
from zero except there were strong genetic and phenotypic
correlations between pairs of subsets where one subset
was part of the other subset e.g. CD4+ and CD4+CD8α+
cells (data not shown).
Discussion
It is essential that markers for increased resistance to infec-
tious disease can be transmitted across generations, i.e. are
heritable. Although we have previously estimated the her-
itability of a range of peripheral blood mononuclear leu-
cocyte subsets and their correlations with performance,
we had not yet been able to robustly examine the influ-
ence of health status upon these parameters [6]. Our cur-
rent dataset comprised animals that were previously
tested [6] along with additional animals from farms that
varied in health status. This data also included additional
immune traits such as CD8α+ cell subsets and acute phase
proteins, AGP, haptoglobin, CRP and transthyretin.
Overall, most of the immune traits tested were found to
be moderately heritable across the dataset as a whole and
these heritabilities, combined with the observed trait var-
iability, would permit selection for altered trait values.
Estimated heritabilities for total and differential white
blood cell (WBC) counts and the acute phase protein,
haptoglobin are similar to those quoted by other workers
[26] (Diack (unpublished observations)). Our heritability
estimates for total and differential white blood cell counts
were within the range of those published by Edfors-Lilja et
al. (1994) and Henryon et al. (2006) [26,27]. Addition-
ally, we were able to provide some novel heritability esti-
mates. For example, unlike humans and other species,
pigs possess high proportions of CD4+CD8α+ cells and we
have provided the first evidence that these subsets are her-
itable. This is arguably unsurprising because these cells are
a subset of total CD4+ cells which are also highly heritable,
and a high genetic correlation was observed between
CD4+CD8α+ cells and CD4+ cells.
Table 6: Correlations between immune traits and average daily gain for SPF and non-SPF pigs1, 2
Farm SPF Non-SPF
Trait rg rp re rg rp re
WBC -0.06 (0.24) -0.03 (0.05) -0.02 (0.12) -0.69 (0.36) -0.10 (0.05) -0.32 (0.10)
MNL% -0.56 (0.44) 0.09 (0.07) 0.35 (0.16) -0.32 (0.37) 0.16 (0.06) -0.11 (0.12)
PMNL% 0.75 (0.40) -0.07 (0.07) -0.40 (0.16) -0.50 (0.34) -0.17 (0.06) -0.04 (0.13)
PBML subsets:
CD4+ -0.15 (0.16) -0.05 (0.05) 0.13 (0.23) -0.10 (0.33) -0.02 (0.06) -0.03 (0.16)
CD8α+ -0.35 (0.20) -0.09 (0.05) 0.10 (0.13) -0.08 (0.36) -0.01 (0.07) -0.06 (0.18)
CD8αβ+ 0.01 (0.25) -0.03 (0.06) -0.05 (0.18) -0.31 (0.42) 0.04 (0.08) -0.07 (0.15)
CD11R1+ total -0.08 (0.20) -0.14 (0.05) -0.19 (0.13) -0.68 (0.29) -0.16 (0.06) -0.05 (0.12)
CD11R1+ CD8+ -0.25 (0.19) -0.11 (0.05) 0.01 (0.14) -0.44 (0.40) -0.05 (0.07) -0.10 (0.14)
CD11R1+ CD8- 0.20 (0.21) -0.07 (0.05) -0.27 (0.13) -0.34 (0.39) -0.18 (0.07) -0.12 (0.13)
γδ+ T cell 0.13 (0.19) 0.17 (0.05) 0.22 (0.13) -0.24 (0.39) 0.15 (0.06) -0.28 (0.11)
B cell -0.01 (0.22) -0.03 (0.05) -0.06 (0.13) -0.33 (0.53) -0.05 (0.06) -0.12 (0.10)
monocytes -0.46 (0.23) -0.17 (0.05) -0.01 (0.12) -0.27 (0.39) -0.02 (0.06) -0.11 (0.11)
CD14+ -0.33 (0.68) -0.18 (0.06) -0.18 (0.13) -0.44 (0.38) -0.07 (0.07) -0.37 (0.19)
CD16+ -0.38 (0.33) -0.19 (0.07) -0.09 (0.17) -3 -3 -3
APP, μg/ml:
haptoglobin -0.18 (0.34) -0.27 (0.06) -0.33 (0.17) -0.13 (0.46) -0.30 (0.05) -0.34 (0.09)
TTR, -0.33 (0.47) -0.16 (0.05) 0.26 (0.16) -0.80 (0.43) -0.09 (0.07) -0.12 (0.14)
CRP -0.12 (0.41) -0.10 (0.07) -0.09 (0.16) -0.22 (0.54) -0.05 (0.06) -0.01 (0.11)
AGP -0.53 (0.20) -0.49 (0.05) -0.46 (0.15) -0.72 (0.22) -0.48 (0.04) -0.42 (0.10)
1Correlations significantly different from zero are shown in bold. 2 White blood cells expressed as no. cells × 106/mL, PBML sub-sets expressed as 
proportion of mononuclear leucocytes and antigen density expressed as the number of antibody binding sites per cell (see Materials and Methods). 
3 Did not converge.Genetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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There was an unexplained maternal effect associated with
the acute phase protein, transthyretin which might not
necessarily be immune-related. Transthyretin mainly acts
as a carrier protein for thyroxine and retinol (vitamin A)
[28]. It is also a marker for nutritional status and is usually
maintained at high levels except during infection and
malnutrition, when it drops [28,29]. Maternal influences
such as maternal stress or nutrition have been shown to
influence transthyretin levels in the off-spring [30,31],
and these effects may well explain our observed maternal
effect.
Most immune traits were heritable regardless of health
status although some immune traits, e.g. the proportions
of mononuclear and polymorphonuclear cells and CD14+
cells, were only observed to be heritable within a lower
health status environment. This is possibly because
genetic differences are more fully expressed for this partic-
ular trait when there are environmental or pathogen chal-
lenges. In our experiments, monocytes were all SIRPα+ but
only a proportion of them were CD14+ and, unlike for
CD14+ cells, health status did not affect the heritability of
monocytes. Pig peripheral blood monocytes are a hetero-
geneous population, both with respect to function and
phenotype and, in pigs, CD14+ cells have been suggested
to represent a more mature population of monocytes
[12,32]. In contrast, other work has shown that exposure
to viral or bacterial pathogens can influence the expres-
sion of CD14 on porcine alveolar macrophages or den-
dritic cells [33,34]. Thus, there might be a stronger genetic
influence upon either monocyte differentiation or the
expression of CD14 in response to the environmental
pathogens present within the lower health status environ-
ment.
Ideally, markers for increased resistance to infectious dis-
ease should correlate (within a herd) with indicators of
health, such as performance, morbidity or mortality. Pre-
vious work by ourselves and others, has demonstrated
negative phenotypic and genetic relationships between
some immune traits and weight gain [4,13,14,35]. This
study confirms and extends these earlier findings. This
type of association could reflect a response to sub-clinical
infection that increases the proliferation of certain
immune cell types and/or the production of acute phase
proteins, with a reduction in growth being a consequence
of infection. The traits that were most strongly and con-
sistently associated with weight gain included the propor-
tions of CD11R1+ cells and monocytes and acute phase
proteins, AGP and haptoglobin. There were also negative
genetic correlations between average daily gain and
immune traits, total CD11R1+ cells, monocytes and AGP.
For total CD11R1+ cells, this effect was only detectable
under non-SPF conditions. The cell marker CD11R1 is
mainly expressed by NK cells [5,6] which are one of the
major defences against intra-cellular pathogens [36].
Since the main pathogens present on the non-SPF farms
were intra-cellular pathogens, e.g. pig circovirus (PCV)
and Mycoplasma hyopneumoniae, then the genetic associa-
tion between CD11R1+ cells and weight gain may reflect a
response to sub-clinical infection. This effect is reinforced
by the observation that correcting for starting weight
strengthened the correlation of average daily gain with
CD11R1+ cells. This, under this type of non-SPF environ-
ment, CD11R1+ cells could act as an indicator for sub-clin-
ical infection.
For monocytes, the genetic relationship between weight
gain and this cell type was only evident under SPF condi-
tions. We cannot fully explain this effect. One major dif-
ference between the SPF and non-SPF animals was that
many of the non-SPF animals came from farms that were
positive for PMWS. PCV is one of the main agents associ-
ated with PMWS and this virus only appears to infect
monocyte/macrophage cell types [37,38]. If viral infection
prevented these cell types from proliferating in response
to infection, then this could have affected the relationship
between these cell types and weight gain under non-SPF
conditions.
Unlike CD11R1+ cells, health status did not affect the
genetic and phenotypic relationships between AGP and
weight gain, which might indicate that this is a more reli-
able indicator for selection purposes. As with other APP,
infection can increase the production of AGP through
cytokines TNF α, IL-1 and IL-6. These cytokines can also
reduce growth by inducing anorexia and tissue break-
down [39-41]. Since AGP concentrations remain raised
for longer after infection than other acute phase proteins
such as CRP and haptoglobin, AGP has been used as a
marker of sub-clinical infection in large scale human stud-
ies [42,43].
In contrast, an alternative view is the lack of any impact of
health status on the relationship between AGP and weight
gain might indicate that the association between AGP and
weight gain is not due to an underlying response to infec-
tion, since AGP is also a constitutive protein. High plasma
AGP concentrations are present after birth and gradually
decrease with age [44,45]. One argument against this view
is that the expression of higher levels of AGP has been
associated with pro- and anti-inflammatory effects which
can influence the outcome of infection and inflammation
[46,47]. In one study, higher constitutive levels of AGP
present in transgenic mice were associated with higher lev-
els of weight loss and inflammation in response to inflam-
matory bowel disease compared to wild-type mice [48].
An analogous situation may exist in pigs where animals
with higher constitutive serum AGP concentrations are
more susceptible to pro-inflammatory tissue damage dueGenetics Selection Evolution 2009, 41:54 http://www.gsejournal.org/content/41/1/54
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to infection, which may lead to reduced weight gain. This
hypothesis could be tested by monitoring AGP and weight
gain in response to direct challenge or disease outbreak, or
by looking for genes that influence both plasma AGP lev-
els and weight gain.
One limitation of this study was that health status was
confounded with farm (i.e. housing and environment),
although husbandry methods were similar between
farms. We attempted to minimise the impact of this con-
founding by statistically accounting for farm in our mod-
els, by placing little importance on mean trait values, as
these could differ for many reasons, but concentrating
instead on genetic variation and relationships between
variables. Performing larger studies on a single farm
would enable us to select genetic parameters that could be
applied to specific health status situations. However, the
generality of our results would be reduced, as we wish to
find parameters that are robust across a wide range of
health environments.
Conclusion
Overall, we have shown that for a wide range of immune
traits, heritabilities were generally unaffected by health
status, although genetic correlations between perform-
ance and CD11R1+ cells or monocytes, were influenced by
health status. There were strong genetic and phenotypic
correlations between AGP and performance, and health
status did not affect the strength of these relationships,
however the genetic association between CD11R1+ cells
and average daily gain was only present under lower
health status conditions. In order to effectively select for
higher performing animals using either of these measure-
ments, we need to fully understand the underlying mech-
anisms that control the relationship between these traits
and weight gain. Also, the relationship of these immune
traits with other immune traits needs to be fully under-
stood to avoid any antagonistic effects. For CD11R1+ cells,
we also need to know the genetic correlations between dif-
ferent health status environments. Future use of these
biomarkers may be conditional on further studies
addressing the implications for complex immune traits of
selecting on single markers. In this context, future work
should focus on finding genetic markers that are linked to
both innate and adaptive immunity and performance,
since such markers would be independent of changes in
health status and they would avoid logistical issues asso-
ciated with measurement of phenotypes.
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